(Q39027326)

English

Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells.

scientific article published on 4 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Human recombinant lysozyme downregulates advanced glycation endproduct-induced interleukin-6 production and release in an in-vitro model of human proximal tubular epithelial cells (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Chiara Agostinis

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Davide Gallo

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Moreno Cocchietto

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Elisa Masat

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Elisa Harei

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Paolo Veronesi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

4 February 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Experimental Biology and Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

239

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

337-346

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24495950%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Assessing the impact of complications on the costs of Type II diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Advanced glycation end products and diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Clinical review: The role of advanced glycation end products in progression and complications of diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Advanced glycation end-products: a review

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Advanced glycation end products: sparking the development of diabetic vascular injury

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Diabetes and advanced glycoxidation end products.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Role of advanced glycation end products in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Characterization of bioactive recombinant human lysozyme expressed in milk of cloned transgenic cattle

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Depletion of reactive advanced glycation endproducts from diabetic uremic sera using a lysozyme-linked matrix

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Amelioration of oxidant stress by the defensin lysozyme

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Advanced glycation end products inhibit Na+ K+ ATPase in proximal tubule epithelial cells: role of cytosolic phospholipase A2alpha and phosphatidylinositol 4-phosphate 5-kinase gamma

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation

1 reference

https://api.crossref.org/works/10.1177%2F1535370213518281

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39027326&oldid=1446521647"